Mitochondrial bound type II hexokinase: a key player in the growth and survival of many cancers and an ideal prospect for therapeutic intervention
Peter L. Pedersen(University of Southern Denmark), Young Hee Ko(Johns Hopkins University), Saroj P. Mathupala(Wayne State University), Annette Rempel(Johns Hopkins University), J.F. Geschwind(Johns Hopkins University)
Cited by 350
Related Papers
Ion motive ATPases. I. Ubiquity, properties, and significance to cell function
|Trends in Biochemical Sciences|1987|966
Hexokinase II: Cancer's double-edged sword acting as both facilitator and gatekeeper of malignancy when bound to mitochondria
|Oncogene|2006|756
Tumor Mitochondria and the Bioenergetics of Cancer Cells
|Progress in tumor research|2015|715
The peripheral-type benzodiazepine receptor. Localization to the mitochondrial outer membrane.
|Journal of Biological Chemistry|1986|691
Hexokinase-2 bound to mitochondria: Cancer's stygian link to the “Warburg effect” and a pivotal target for effective therapy
|Seminars in Cancer Biology|2008|585